Vibrant Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $61M

  • Investors
  • 9

Vibrant Therapeutics General Information

Description

Developer of an AI-driven smart macromolecular drug development platform intended to serve the industry. The company focuses on fields that face significant unmet medical needs, such as AI in tumour immunotherapy, and is committed to building a macromolecule drug development platform to enhance the quality and efficiency of macromolecule drug research and development.

Contact Information

Website
www.vibrantx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 18 Shenzhou Road
  • D13 Floor
  • Guangzhou, Guangdong 510663
  • China
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 18 Shenzhou Road
  • D13 Floor
  • Guangzhou, Guangdong 510663
  • China

Vibrant Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vibrant Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 12-Jan-2026 $61M Completed Generating Revenue
4. Early Stage VC (Series A1) 25-Aug-2025 Completed Generating Revenue
3. Secondary Transaction - Private 01-Mar-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 13-Jan-2022 $12.5M $12.5M Completed Generating Revenue
1. Early Stage VC 21-Dec-2020 Completed Generating Revenue
To view Vibrant Therapeutics’s complete valuation and funding history, request access »

Vibrant Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vibrant Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bayland Capital Corporate Venture Capital Minority
First Principles Ventures Venture Capital Minority
HSG Corporation Minority
Northern Light Venture Capital Venture Capital Minority
Pfizer Ventures Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Vibrant Therapeutics FAQs

  • When was Vibrant Therapeutics founded?

    Vibrant Therapeutics was founded in 2019.

  • Where is Vibrant Therapeutics headquartered?

    Vibrant Therapeutics is headquartered in Guangzhou, China.

  • What is the size of Vibrant Therapeutics?

    Vibrant Therapeutics has 5 total employees.

  • What industry is Vibrant Therapeutics in?

    Vibrant Therapeutics’s primary industry is Discovery Tools (Healthcare).

  • Is Vibrant Therapeutics a private or public company?

    Vibrant Therapeutics is a Private company.

  • What is Vibrant Therapeutics’s current revenue?

    The current revenue for Vibrant Therapeutics is .

  • How much funding has Vibrant Therapeutics raised over time?

    Vibrant Therapeutics has raised $73.5M.

  • Who are Vibrant Therapeutics’s investors?

    Bayland Capital, First Principles Ventures, HSG, Northern Light Venture Capital, and Pfizer Ventures are 5 of 9 investors who have invested in Vibrant Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process